ES2085665T3 - Agente neuroprotector. - Google Patents
Agente neuroprotector.Info
- Publication number
- ES2085665T3 ES2085665T3 ES93102957T ES93102957T ES2085665T3 ES 2085665 T3 ES2085665 T3 ES 2085665T3 ES 93102957 T ES93102957 T ES 93102957T ES 93102957 T ES93102957 T ES 93102957T ES 2085665 T3 ES2085665 T3 ES 2085665T3
- Authority
- ES
- Spain
- Prior art keywords
- neuroprotector
- agent
- cerebral
- neuroprotecting
- distrubance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
UN FARMACO NEUROPROTECTOR QUE CONTIENE COMO UN INGREDIENTE ACTIVO ESENCIAL ETIL 2-[4,5-BIS(4-METOXIFENIL)TIAZOL-2-IL]PIRROL1-IL ACETATO QUE ES UTIL Y MUY SEGURO PARA LA PROFILAXIS Y TRATAMIENTO DE LA DISFUNCION CEREBRAL INDUCIDA POR LA HIPOXIA DEBIDA A UNA ALTERACION DE LA CIRCULACION CEREBRAL TALES COMO LA HEMORRAGIA CEREBRAL O EL INFARTO CEREBRAL EN SERES HUMANOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4075256A JPH05229943A (ja) | 1992-02-25 | 1992-02-25 | 脳保護剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2085665T3 true ES2085665T3 (es) | 1996-06-01 |
Family
ID=13570960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93102957T Expired - Lifetime ES2085665T3 (es) | 1992-02-25 | 1993-02-25 | Agente neuroprotector. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5399571A (es) |
EP (1) | EP0560136B1 (es) |
JP (1) | JPH05229943A (es) |
KR (1) | KR100247845B1 (es) |
AT (1) | ATE133335T1 (es) |
DE (1) | DE69301360T2 (es) |
DK (1) | DK0560136T3 (es) |
ES (1) | ES2085665T3 (es) |
GR (1) | GR3018787T3 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003213351A1 (en) | 2002-03-14 | 2003-09-22 | Takeda Chemical Industries, Ltd. | Vdac regulator |
JP4484439B2 (ja) * | 2002-03-14 | 2010-06-16 | 国立大学法人東京工業大学 | Vdac調節剤 |
US9289168B2 (en) * | 2008-12-29 | 2016-03-22 | Medtronic Minimed, Inc. | System and/or method for glucose sensor calibration |
US10471207B2 (en) | 2008-12-29 | 2019-11-12 | Medtronic Minimed, Inc. | System and/or method for glucose sensor calibration |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4168315A (en) * | 1977-09-28 | 1979-09-18 | The Upjohn Company | Dianisyl thiazole compound, compositions and method of antithrombotic treatment |
US4659726A (en) * | 1984-04-19 | 1987-04-21 | Kanebo, Ltd. | Novel 4,5-Bis (4-methoxyphenyl)-2-(pyrrol-2-yl) thiazoles and pharmaceutical composition containing the same |
-
1992
- 1992-02-25 JP JP4075256A patent/JPH05229943A/ja active Pending
-
1993
- 1993-02-12 US US08/016,860 patent/US5399571A/en not_active Expired - Fee Related
- 1993-02-24 KR KR1019930002589A patent/KR100247845B1/ko not_active IP Right Cessation
- 1993-02-25 AT AT93102957T patent/ATE133335T1/de not_active IP Right Cessation
- 1993-02-25 DK DK93102957.3T patent/DK0560136T3/da active
- 1993-02-25 ES ES93102957T patent/ES2085665T3/es not_active Expired - Lifetime
- 1993-02-25 EP EP93102957A patent/EP0560136B1/en not_active Expired - Lifetime
- 1993-02-25 DE DE69301360T patent/DE69301360T2/de not_active Expired - Fee Related
-
1996
- 1996-01-25 GR GR950403720T patent/GR3018787T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3018787T3 (en) | 1996-04-30 |
DE69301360D1 (de) | 1996-03-07 |
US5399571A (en) | 1995-03-21 |
DE69301360T2 (de) | 1996-07-11 |
JPH05229943A (ja) | 1993-09-07 |
DK0560136T3 (da) | 1996-02-26 |
EP0560136A1 (en) | 1993-09-15 |
KR930017579A (ko) | 1993-09-20 |
EP0560136B1 (en) | 1996-01-24 |
KR100247845B1 (ko) | 2000-04-01 |
ATE133335T1 (de) | 1996-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0587377A3 (en) | Thiazolidinone derivatives as hypoglycemic agents and for treating alzheimer's disease | |
FI935306A (fi) | Puhdistettujen, pintaa modifioivien aineiden käyttö estämään hiukkasten kasautumista steriloinnin aikana | |
HRP920667A2 (en) | Application of fultripine active substance for preventing muscle deformation | |
ZA896150B (en) | The use of alpha-amino boronic acid derivatives for the prophylaxis and treatment of virus diseases | |
DE3875866D1 (de) | Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie. | |
NO943521L (no) | Anvendelse av et pyrrolidinacetamidderivat for fremstilling av et terapeutikum | |
ES2093357T3 (es) | Metodo de tratamiento de la alopecia. | |
ES2085665T3 (es) | Agente neuroprotector. | |
IT1271567B (it) | Procedimento per l'ulteriore trattamento di salcicce | |
AU7935887A (en) | Therapeutic agent for the treatment of peptic ulcer disease | |
NO970185D0 (no) | Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi | |
NO960545D0 (no) | Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin | |
NO923198L (no) | Terapeutiske midler | |
DE68901172D1 (de) | (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend. | |
EP0454429A3 (en) | Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases | |
IL98200A0 (en) | Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide | |
SE8703308D0 (sv) | Therapeutic agent for the treatment of disorders associated with cerebral ischemia | |
FR2691064B3 (fr) | Nouveau medicament pour le traitement de l'arythmie. | |
AU1494395A (en) | The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases | |
ITMI920161A1 (it) | Medicamento contenente arg-gly-asp per il trattamento del glaucoma | |
IT1244562B (it) | Agente per la prevenzione ed il trattamento dell'opacita' del cristallino. | |
ES2039255T3 (es) | Utilizacion de n-((1-etil-2-pirrolidinil)metil)-2-metoxi-5-sulfamoil-benzamida en el tratamiento de la esterilidad. | |
FI945035A0 (fi) | Pintasterilisointi laserkäsittelyn avulla | |
IL111017A0 (en) | Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine and its use for the treatment of alzheimer's disease | |
DK8893D0 (da) | Medicament for treatment or prevention of disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 560136 Country of ref document: ES |